As Prices for Prenatal Genome Sequencing Tests Fall, Researchers Worry About Consequences for Families in a Real-Life 'Gattaca'
By Makini Brice,
Medical Daily
| 08. 13. 2012
If you could know your unborn child's entire genetic makeup, would you want to? Researchers believe that tests that detail your unborn fetus's entire genome will soon be available for under $1,000, putting it within the price point that many people would be willing to pay. One team of researchers worry about the potential ramifications that this knowledge could have, for parents, for children, for families and for society.
Genome sequencing differs from current genetic tests, both ethically and practically, Greer Donley, a law student at the University of Michigan, and her team of researchers say. Current genetic tests identify the risks of certain genetic anomalies for fetuses at high risk of them. Genome sequencing, on the other hand, would be sought by a much larger group of future parents. Most importantly, genome sequencing would drastically increase the volume and scope of prenatal data, including a wide range of genetic traits and disease susceptibility.
Donley and her fellow investigators cited three specific areas of concern. The quality and quantity of information in existence, and the changing definition of "normal", may...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...